Susanna Gatti High Dyne Therapeutics, Inc. (DYN) insider trading activity

Susanna Gatti High is Chief Operating Officer of Dyne Therapeutics, Inc.. Currently has a direct ownership of 131,636 shares of DYN, which is worth approximately $3.16 Million. The most recent transaction as insider was on Sep 18, 2024, when has been sold 8,976 shares (Common Stock) at a price of $34.41 per share, resulting in proceeds of $308,864. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 132K

0% 3M change

29.94% 12M change

Total Value Held $3.16 Million

SUSANNA GATTI HIGH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 18 2024	SELL Open market or private sale	$308,864 $34.41 p/Share	8,976 Reduced 6.38%	131,636 Common Stock
Sep 11 2024	SELL Open market or private sale	$168,060 $31.89 p/Share	5,270 Reduced 3.61%	140,612 Common Stock
Aug 19 2024	SELL Open market or private sale	$132,405 $45.5 p/Share	2,910 Reduced 1.96%	145,882 Common Stock
Jun 24 2024	SELL Open market or private sale	$359,058 $35.33 p/Share	10,163 Reduced 6.39%	148,792 Common Stock
Jun 24 2024	BUY Exercise of conversion of derivative security	$56,303 $5.54 p/Share	10,163 Added 6.01%	158,955 Common Stock
Jun 21 2024	SELL Open market or private sale	$1,042,842 $35.01 p/Share	29,787 Reduced 16.68%	148,792 Common Stock
Jun 21 2024	BUY Exercise of conversion of derivative security	$165,019 $5.54 p/Share	29,787 Added 14.3%	178,579 Common Stock
Jun 12 2024	SELL Open market or private sale	$1,337,200 $33.43 p/Share	40,000 Reduced 21.19%	148,792 Common Stock
Jun 12 2024	BUY Exercise of conversion of derivative security	$221,600 $5.54 p/Share	40,000 Added 17.48%	188,792 Common Stock
Jun 11 2024	SELL Open market or private sale	$164,582 $31.23 p/Share	5,270 Reduced 3.42%	148,792 Common Stock
Jun 10 2024	SELL Open market or private sale	$2,419,200 $30.24 p/Share	80,000 Reduced 34.18%	154,062 Common Stock
Jun 10 2024	BUY Exercise of conversion of derivative security	$443,200 $5.54 p/Share	80,000 Added 25.47%	234,062 Common Stock
May 16 2024	SELL Open market or private sale	$77,759 $28.4 p/Share	2,738 Reduced 1.75%	154,062 Common Stock
Mar 11 2024	SELL Open market or private sale	$58,904 $25.7 p/Share	2,292 Reduced 1.44%	156,800 Common Stock
Mar 08 2024	SELL Open market or private sale	$735,460 $27.04 p/Share	27,199 Reduced 14.6%	159,092 Common Stock
Mar 07 2024	SELL Open market or private sale	$41,127 $25.85 p/Share	1,591 Reduced 0.85%	186,291 Common Stock
Dec 11 2023	SELL Open market or private sale	$17,323 $10.72 p/Share	1,616 Reduced 0.85%	187,882 Common Stock
Nov 15 2023	BUY Grant, award, or other acquisition	-	94,893 Added 33.37%	189,498 Common Stock
Nov 02 2023	SELL Open market or private sale	$73,548 $7.4 p/Share	9,939 Reduced 9.51%	94,605 Common Stock
Sep 18 2023	SELL Open market or private sale	$25,143 $9.41 p/Share	2,672 Reduced 2.49%	104,544 Common Stock
Sep 12 2023	SELL Open market or private sale	$17,020 $10.41 p/Share	1,635 Reduced 1.5%	107,216 Common Stock
Jun 13 2023	SELL Open market or private sale	$20,198 $12.43 p/Share	1,625 Reduced 1.47%	108,851 Common Stock
Mar 14 2023	SELL Open market or private sale	$20,781 $13.33 p/Share	1,559 Reduced 1.39%	110,476 Common Stock
Dec 12 2022	SELL Open market or private sale	$8,163 $10.87 p/Share	751 Reduced 0.67%	112,035 Common Stock
Dec 09 2022	BUY Grant, award, or other acquisition	-	44,000 Added 28.06%	112,786 Common Stock

SGH

Susanna Gatti High

Chief Operating Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DYN shares.

Notify only if

Value

Insider Trading

Get notified when an Dyne Therapeutics, Inc. insider buys or sells DYN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Dyne Therapeutics, Inc.

Track Activities on DYN

Account